Eculizumab 300mg/30ml solution for infusion vials
NHS hospitals in England used £27,675,900 of indicative cost of Eculizumab 300mg/30ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 5.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Eculizumab 300mg/30ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Eculizumab 300mg/30ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Leeds Teaching Hpls Nhs Trust | £4,914,000 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,686,950 |
| King's College Hpl Nhs Foundation Trust | £1,792,350 |
| Royal Devon & Exeter Nhs Foundation Trst | £1,682,100 |
| Manchester University Nhs Ft | £1,650,600 |
| Imperial College Healthcare Nhs Trust | £979,650 |
| Guy's & St Thomas' Nhs Foundation Trust | £932,400 |
| Portsmouth Hospitals Nhs Trust | £847,350 |
| Barts Health Nhs Trust | £774,900 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £718,200 |
The primary-care picture
Eculizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Eculizumab medicine page.